Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016, Article ID 6579463, 17 pages
http://dx.doi.org/10.1155/2016/6579463
Research Article

Mesenchymal Stromal Cells from Osteoarthritic Synovium Are a Distinct Population Compared to Their Bone-Marrow Counterparts regarding Surface Marker Distribution and Immunomodulation of Allogeneic CD4+ T-Cell Cultures

1Clinic for Orthopedics and Trauma Surgery, Center for Orthopedics, Trauma Surgery and Spinal Cords Injury, Heidelberg University Hospital, Schlierbacher Landstrasse 200a, 69118 Heidelberg, Germany
2St. Vincentius Hospital Karlsruhe, Department of Internal Medicine III, Südendstraße 32, 76137 Karlsruhe, Germany

Received 10 March 2016; Accepted 13 June 2016

Academic Editor: Thomas Ichim

Copyright © 2016 Sebastien Hagmann et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. C. Lawrence, D. T. Felson, C. G. Helmick et al., “Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II,” Arthritis and Rheumatism, vol. 58, no. 1, pp. 26–35, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. D. J. Hunter and D. T. Felson, “Osteoarthritis,” The British Medical Journal, vol. 332, no. 7542, pp. 639–642, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Kurtz, F. Mowat, K. Ong, N. Chan, E. Lau, and M. Halpern, “Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through 2002,” The Journal of Bone and Joint Surgery—Series A, vol. 87, no. 7, pp. 1487–1497, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. M. B. Goldring and M. Otero, “Inflammation in osteoarthritis,” Current Opinion in Rheumatology, vol. 23, no. 5, pp. 471–478, 2011. View at Publisher · View at Google Scholar
  5. J. Sellam and F. Berenbaum, “The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis,” Nature Reviews Rheumatology, vol. 6, no. 11, pp. 625–635, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. S. L. Myers, K. D. Brandt, J. W. Ehlich et al., “Synovial inflammation in patients with early osteoarthritis of the knee,” The Journal of Rheumatology, vol. 17, no. 12, pp. 1662–1669, 1990. View at Google Scholar · View at Scopus
  7. P. A. Revell, V. Mayston, P. Lalor, and P. Mapp, “The synovial membrane in osteoarthritis: a histological study including the characterisation of the cellular infiltrate present in inflammatory osteoarthritis using monoclonal antibodies,” Annals of the Rheumatic Diseases, vol. 47, no. 4, pp. 300–307, 1988. View at Publisher · View at Google Scholar · View at Scopus
  8. C. R. Scanzello and S. R. Goldring, “The role of synovitis in osteoarthritis pathogenesis,” Bone, vol. 51, no. 2, pp. 249–257, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. M. D. Smith, S. Triantafillou, A. Parker, P. P. Youssef, and M. Coleman, “Synovial membrane inflammation and cytokine production in patients with early osteoarthritis,” The Journal of Rheumatology, vol. 24, no. 2, pp. 365–371, 1997. View at Google Scholar · View at Scopus
  10. L. Young, A. Katrib, C. Cuello et al., “Effects of intraarticular glucocorticoids on macrophage infiltration and mediators of joint damage in osteoarthritis synovial membranes: findings in a double-blind, placebo-controlled study,” Arthritis and Rheumatism, vol. 44, no. 2, pp. 343–350, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. F. W. Roemer, A. Guermazi, D. T. Felson et al., “Presence of MRI-detected joint effusion and synovitis increases the risk of cartilage loss in knees without osteoarthritis at 30-month follow-up: The MOST Study,” Annals of the Rheumatic Diseases, vol. 70, no. 10, pp. 1804–1809, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Augello, R. Tasso, S. M. Negrini, R. Cancedda, and G. Pennesi, “Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis,” Arthritis & Rheumatism, vol. 56, no. 4, pp. 1175–1186, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Jones, S. M. Churchman, A. English et al., “Mesenchymal stem cells in rheumatoid synovium: enumeration and functional assessment in relation to synovial inflammation level,” Annals of the Rheumatic Diseases, vol. 69, no. 2, pp. 450–457, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Hagmann, T. Gotterbarm, T. Müller et al., “The influence of bone marrow- and synovium-derived mesenchymal stromal cells from osteoarthritis patients on regulatory T cells in co-culture,” Clinical and Experimental Immunology, vol. 173, no. 3, pp. 454–462, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Moradi, P. Schnatzer, S. Hagmann et al., “CD4+CD25+/highCD127low/- regulatory T cells are enriched in rheumatoid arthritis and osteoarthritis joints—analysis of frequency and phenotype in synovial membrane, synovial fluid and peripheral blood,” Arthritis Research & Therapy, vol. 16, no. 2, article R97, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Hagmann, B. Moradi, S. Frank et al., “FGF-2 addition during expansion of human bone marrow-derived stromal cells alters MSC surface marker distribution and chondrogenic differentiation potential,” Cell Proliferation, vol. 46, no. 4, pp. 396–407, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. M. A. Boks, J. J. Zwaginga, S. M. van Ham, and A. ten Brinke, “An optimized CFSE-based T-cell suppression assay to evaluate the suppressive capacity of regulatory T-cells induced by human tolerogenic dendritic cells,” Scandinavian Journal of Immunology, vol. 72, no. 2, pp. 158–168, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Dominici, K. Le Blanc, I. Mueller et al., “Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement,” Cytotherapy, vol. 8, no. 4, pp. 315–317, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Halfon, N. Abramov, B. Grinblat, and I. Ginis, “Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging,” Stem Cells and Development, vol. 20, no. 1, pp. 53–66, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Baksh, R. Yao, and R. S. Tuan, “Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow,” Stem Cells, vol. 25, no. 6, pp. 1384–1392, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. K. C. Russell, D. G. Phinney, M. R. Lacey, B. L. Barrilleaux, K. E. Meyertholen, and K. C. O'Connor, “In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment,” Stem Cells, vol. 28, no. 4, pp. 788–798, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. L. V. Schnabel, L. M. Pezzanite, D. F. Antczak, M. J. B. Felippe, and L. A. Fortier, “Equine bone marrow-derived mesenchymal stromal cells are heterogeneous in MHC class II expression and capable of inciting an immune response in vitro,” Stem Cell Research and Therapy, vol. 5, no. 1, article 13, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Romieu-Mourez, M. François, M.-N. Boivin, J. Stagg, and J. Galipeau, “Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-γ, TGF-β, and cell density,” The Journal of Immunology, vol. 179, no. 3, pp. 1549–1558, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Bocelli-Tyndall, P. Zajac, N. Di Maggio et al., “Fibroblast growth factor 2 and platelet-derived growth factor, but not platelet lysate, induce proliferation-dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cells,” Arthritis and Rheumatism, vol. 62, no. 12, pp. 3815–3825, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. C. H. Jo, H. J. Ahn, H. J. Kim, S. C. Seong, and M. C. Lee, “Surface characterization and chondrogenic differentiation of mesenchymal stromal cells derived from synovium,” Cytotherapy, vol. 9, no. 4, pp. 316–327, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Le Blanc, L. Tammik, B. Sundberg, S. E. Haynesworth, and O. Ringdén, “Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex,” Scandinavian Journal of Immunology, vol. 57, no. 1, pp. 11–20, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Lee, S. Y. Jeong, J. Ha et al., “Low immunogenicity of allogeneic human umbilical cord blood-derived mesenchymal stem cells in vitro and in vivo,” Biochemical and Biophysical Research Communications, vol. 446, no. 4, pp. 983–989, 2014. View at Publisher · View at Google Scholar
  28. M. Di Ianni, B. Del Papa, M. De Ioanni et al., “Mesenchymal cells recruit and regulate T regulatory cells,” Experimental Hematology, vol. 36, no. 3, pp. 309–318, 2008. View at Publisher · View at Google Scholar
  29. J. Cuerquis, R. Romieu-Mourez, M. François et al., “Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation,” Cytotherapy, vol. 16, no. 2, pp. 191–202, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. Z. Zhao, W. Xu, L. Sun, W. Li, Q. Li, and P. Zou, “The characteristics and immunoregulatory functions of regulatory dendritic cells induced by mesenchymal stem cells derived from bone marrow of patient with chronic myeloid leukaemia,” European Journal of Cancer, vol. 48, no. 12, pp. 1884–1895, 2012. View at Publisher · View at Google Scholar
  31. P. Luz-Crawford, M. Kurte, J. Bravo-Alegría et al., “Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells,” Stem Cell Research and Therapy, vol. 4, no. 3, article 65, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Lin, H. Ma, Z. Ding et al., “Bone marrow-derived mesenchymal stem cells favor the immunosuppressive T cells skewing in a Helicobacter pylori model of gastric cancer,” Stem Cells and Development, vol. 22, no. 21, pp. 2836–2848, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. K. H. Yoo, I. K. Jang, M. W. Lee et al., “Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues,” Cellular Immunology, vol. 259, no. 2, pp. 150–156, 2009. View at Publisher · View at Google Scholar
  34. Z. Zhang, Y. Ding, W. Li, B. Song, and R. Yang, “Interleukin-17A- or tumor necrosis factor α-mediated increase in proliferation of T cells cocultured with synovium-derived mesenchymal stem cells in rheumatoid arthritis,” Arthritis Research and Therapy, vol. 15, no. 5, article R169, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. M. D. Nicola, C. Carlo-Stella, M. Magni et al., “Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli,” Blood, vol. 99, no. 10, pp. 3838–3843, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Åroøen, S. Løken, S. Heir et al., “Articular cartilage lesions in 993 consecutive knee arthroscopies,” American Journal of Sports Medicine, vol. 32, no. 1, pp. 211–215, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Kapoor, J. Martel-Pelletier, D. Lajeunesse, J.-P. Pelletier, and H. Fahmi, “Role of proinflammatory cytokines in the pathophysiology of osteoarthritis,” Nature Reviews Rheumatology, vol. 7, no. 1, pp. 33–42, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. P. G. Conaghan, M. A. D'Agostino, M. Le Bars et al., “Clinical and ultrasonographic predictors of joint replacement for knee osteoarthritis: results from a large, 3-year, prospective EULAR study,” Annals of the Rheumatic Diseases, vol. 69, no. 4, pp. 644–647, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. C. H. Jo, Y. G. Lee, W. H. Shin et al., “Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-concept clinical trial,” STEM CELLS, vol. 32, no. 5, pp. 1254–1266, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Ivanova-Todorova, I. Bochev, R. Dimitrov et al., “Conditioned medium from adipose tissue-derived mesenchymal stem cells induces CD4+FOXP3+ cells and increases IL-10 secretion,” Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 295167, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Li, S.-H. Li, J. Wu et al., “Interleukin-6 downregulation with mesenchymal stem cell differentiation results in loss of immunoprivilege,” Journal of Cellular and Molecular Medicine, vol. 17, no. 9, pp. 1136–1145, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. P. Cipriani, P. Di Benedetto, V. Liakouli et al., “Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy,” Clinical and Experimental Immunology, vol. 173, no. 2, pp. 195–206, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. Z. G. Zhao, Z. Cao, W. Xu et al., “Immune protection function of multipotent mesenchymal stromal cells: role of transforming growth factor-β1,” Cancer Investigation, vol. 30, no. 9, pp. 646–656, 2012. View at Publisher · View at Google Scholar
  44. E. Svobodova, M. Krulova, A. Zajicova et al., “The role of mouse mesenchymal stem cells in differentiation of naive T-cells into anti-inflammatory regulatory T-cell or proinflammatory helper T-cell 17 population,” Stem Cells and Development, vol. 21, no. 6, pp. 901–910, 2012. View at Publisher · View at Google Scholar · View at Scopus